Report Detail

Pharma & Healthcare Global Levothyroxine Sodium Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3787132
  • |
  • 27 September, 2019
  • |
  • Global
  • |
  • 109 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Description

Scope of the Report:
The worldwide market for Levothyroxine Sodium is expected to grow at a CAGR of roughly 2.6% over the next five years, will reach 3810.4 million US$ in 2024, from 3434.3 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Levothyroxine Sodium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Abbvie
IBSA
Pfizer
Mylan Pharma
Fresenius Kabi
Merck
Abbott
Novartis
Lannett Company
Piramal Critical Care

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
Injection

Oral had a market share of 99% in 2018.

Market Segment by Applications, can be divided into
Hospitals
Pharmacy
Others

Pharmacy is the greatest segment of Levothyroxine Sodium application, with a share of 63% in 2018.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Levothyroxine Sodium product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Levothyroxine Sodium, with price, sales, revenue and global market share of Levothyroxine Sodium in 2017 and 2018.
Chapter 3, the Levothyroxine Sodium competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Levothyroxine Sodium breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Levothyroxine Sodium market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Levothyroxine Sodium sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Levothyroxine Sodium Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Oral
      • 1.2.2 Injection
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospitals
      • 1.3.2 Pharmacy
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Abbvie
      • 2.1.1 Business Overview
      • 2.1.2 Levothyroxine Sodium Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Abbvie Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 IBSA
      • 2.2.1 Business Overview
      • 2.2.2 Levothyroxine Sodium Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 IBSA Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Pfizer
      • 2.3.1 Business Overview
      • 2.3.2 Levothyroxine Sodium Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Pfizer Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Mylan Pharma
      • 2.4.1 Business Overview
      • 2.4.2 Levothyroxine Sodium Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Mylan Pharma Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Fresenius Kabi
      • 2.5.1 Business Overview
      • 2.5.2 Levothyroxine Sodium Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Fresenius Kabi Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Merck
      • 2.6.1 Business Overview
      • 2.6.2 Levothyroxine Sodium Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Merck Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Abbott
      • 2.7.1 Business Overview
      • 2.7.2 Levothyroxine Sodium Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Abbott Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Novartis
      • 2.8.1 Business Overview
      • 2.8.2 Levothyroxine Sodium Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Novartis Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Lannett Company
      • 2.9.1 Business Overview
      • 2.9.2 Levothyroxine Sodium Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Lannett Company Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Piramal Critical Care
      • 2.10.1 Business Overview
      • 2.10.2 Levothyroxine Sodium Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Piramal Critical Care Levothyroxine Sodium Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Levothyroxine Sodium Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Levothyroxine Sodium Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Levothyroxine Sodium Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Levothyroxine Sodium Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Levothyroxine Sodium Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Levothyroxine Sodium Market Analysis by Regions

    • 4.1 Global Levothyroxine Sodium Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Levothyroxine Sodium Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Levothyroxine Sodium Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 4.3 Europe Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 4.5 South America Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Levothyroxine Sodium Sales and Growth Rate (2014-2019)

    5 North America Levothyroxine Sodium by Country

    • 5.1 North America Levothyroxine Sodium Sales, Revenue and Market Share by Country
      • 5.1.1 North America Levothyroxine Sodium Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Levothyroxine Sodium Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 5.3 Canada Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Levothyroxine Sodium Sales and Growth Rate (2014-2019)

    6 Europe Levothyroxine Sodium by Country

    • 6.1 Europe Levothyroxine Sodium Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Levothyroxine Sodium Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Levothyroxine Sodium Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 6.3 UK Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 6.4 France Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 6.5 Russia Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 6.6 Italy Levothyroxine Sodium Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Levothyroxine Sodium by Country

    • 7.1 Asia-Pacific Levothyroxine Sodium Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Levothyroxine Sodium Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Levothyroxine Sodium Revenue and Market Share by Country (2014-2019)
    • 7.2 China Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 7.3 Japan Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 7.4 Korea Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 7.5 India Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Levothyroxine Sodium Sales and Growth Rate (2014-2019)

    8 South America Levothyroxine Sodium by Country

    • 8.1 South America Levothyroxine Sodium Sales, Revenue and Market Share by Country
      • 8.1.1 South America Levothyroxine Sodium Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Levothyroxine Sodium Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Levothyroxine Sodium Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Levothyroxine Sodium by Countries

    • 9.1 Middle East and Africa Levothyroxine Sodium Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Levothyroxine Sodium Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Levothyroxine Sodium Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Levothyroxine Sodium Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Levothyroxine Sodium Sales and Growth Rate (2014-2019)

    10 Global Levothyroxine Sodium Market Segment by Type

    • 10.1 Global Levothyroxine Sodium Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Levothyroxine Sodium Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Levothyroxine Sodium Revenue and Market Share by Type (2014-2019)
    • 10.2 Oral Sales Growth and Price
      • 10.2.1 Global Oral Sales Growth (2014-2019)
      • 10.2.2 Global Oral Price (2014-2019)
    • 10.3 Injection Sales Growth and Price
      • 10.3.1 Global Injection Sales Growth (2014-2019)
      • 10.3.2 Global Injection Price (2014-2019)

    11 Global Levothyroxine Sodium Market Segment by Application

    • 11.1 Global Levothyroxine Sodium Sales Market Share by Application (2014-2019)
    • 11.2 Hospitals Sales Growth (2014-2019)
    • 11.3 Pharmacy Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Levothyroxine Sodium Market Forecast (2019-2024)

    • 12.1 Global Levothyroxine Sodium Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Levothyroxine Sodium Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Levothyroxine Sodium Market Forecast (2019-2024)
      • 12.2.2 Europe Levothyroxine Sodium Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Levothyroxine Sodium Market Forecast (2019-2024)
      • 12.2.4 South America Levothyroxine Sodium Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Levothyroxine Sodium Market Forecast (2019-2024)
    • 12.3 Levothyroxine Sodium Market Forecast by Type (2019-2024)
      • 12.3.1 Global Levothyroxine Sodium Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Levothyroxine Sodium Market Share Forecast by Type (2019-2024)
    • 12.4 Levothyroxine Sodium Market Forecast by Application (2019-2024)
      • 12.4.1 Global Levothyroxine Sodium Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Levothyroxine Sodium Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Levothyroxine Sodium. Industry analysis & Market Report on Levothyroxine Sodium is a syndicated market report, published as Global Levothyroxine Sodium Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Levothyroxine Sodium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,731.80
      4,097.70
      5,463.60
      3,208.56
      4,812.84
      6,417.12
      546,325.20
      819,487.80
      1,092,650.40
      289,222.80
      433,834.20
      578,445.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report